Ophthalmic Innovation 2016 - "A View From The AAO"
Presenter:
David Parke, II, MD, CEO
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
2. The Big Three
⢠V2V: âVOLUME TO VALUEâ
⢠A2A: âANECDOTESâ TO âANALYTICSâ
⢠P2P: âPATIENTS TO POPULATIONSâ
2
3. V2V: Health Care Payments
3
VALUE =
QUALITY
COST
VALUE = healthcare outcomes achieved
per dollar spent
4. Measuring the âRight Stuffâ
⢠What is the most important factor in surgery?
1. Judgment as to whether to operate or not
2. Which procedure to perform given clinical factors
3. Intraoperative technical skill
4. Whether guidelines followed for antimicrobial prophylaxis
4
5. MACRA
ď§ Fundamentally changes the way Medicare
determines and updates payments to physicians
(and hospitals and ASCâs)
ď§ Goes into effect January 2017
ď§ Final rules this week
5
6. Impact for Industry
⢠Within three years, 30% of each ophthalmologistâs individual score
will be based on âresource useâ or total cost
⢠Cataract surgery: site of service (ASC vs HOPD)
⢠Retina: choice of anti-VEGF agent
⢠Impact on physician payment and behavior:
⢠up to 9% of total Medicare payments at risk
6
9. IRIS Impact: New Knowledge to Measure âValueâ
9
⢠Natural history data
⢠Prevalence data
⢠Treatment impacts
⢠Drug interactions
⢠Complications
⢠Rare diseases
12. ⢠RebrandingâAAO and the profession
⢠Communicating externally
⢠Engaging the patient
⢠Demonstrating value
⢠Thinking about populations of patients
P2P: Patients to Populations:
Repositioning the Profession
16. NASEM Study:
Reprioritizing Eye Health
⢠Examine the core principles and public health strategies
to reduce visual impairment and promote eye health in
the United States.
⢠Action plan for public and private collaborations at the
community, state, and national levels to elevate vision
and eye health as a public health issue.
16